ZIDOVUDINE FOR THE REDUCTION OF PERINATAL HUMAN-IMMUNODEFICIENCY-VIRUS TRANSMISSION - PEDIATRIC AIDS CLINICAL-TRIALS GROUP PROTOCOL-076 - RESULTS AND TREATMENT RECOMMENDATIONS

被引：0
|
作者：
CONNOR, EM [1 ]
MOFENSON, LM [1 ]
机构：
[1] NICHHD, CTR RES MOTHERS & CHILDRENS, PEDIAT ADOLESCENT & MATERNAL AIDS BRANCH, BETHESDA, MD USA
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 1995年 / 14卷 / 06期
关键词：
ZIDOVUDINE; HUMAN IMMUNODEFICIENCY VIRUS; PERINATAL TRANSMISSION;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：536 / 541
页数：6
相关论文
共 46 条
  • [31] Randomized study of the tolerance and efficacy of high- versus low-dose zidovudine in human immunodeficiency virus-infected children with mild to moderate symptoms (AIDS Clinical Trials Group 128)
    Brady, MT
    McGrath, N
    Brouwers, P
    Gelber, R
    Fowler, MG
    Yogev, R
    Hutton, N
    Bryson, YJ
    Mitchell, CD
    Fikrig, S
    Borkowsky, W
    Jimenez, E
    McSherry, G
    Rubinstein, A
    Wilfert, CM
    McIntosh, K
    Elkins, MM
    Weintrub, PS
    Bernstein, L
    Shliozberg, J
    Livingston, RA
    Vink, P
    Flautt, L
    Kline, MW
    Rayborn, T
    Kaul, A
    Lawrence, R
    Chandwani, S
    RubinHale, A
    KnoxBurke, K
    AlAttar, I
    Cooper, ER
    Pelton, SI
    Regan, AM
    Damon, B
    Young, B
    Nozyce, M
    Cihak, P
    Wiznia, A
    Chadwick, EG
    Silio, M
    Klauke, BJ
    Oleske, JM
    Colabelli, NB
    Connor, EM
    Gershon, A
    Pitt, J
    Shea, K
    Clark, P
    Cervia, JS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (05): : 1097 - 1106
  • [32] Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS clinical trials group protocol 360)
    Erice, A
    Tierney, C
    Hirsch, M
    Caliendo, AM
    Weinberg, A
    Kendall, MA
    Polsky, B
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (04) : 567 - 578
  • [33] Safety and efficacy of extended-release niacin for the treatment of dyslipidemia in patients with human immunodeficiency virus infection:: A multicenter study (AIDS clinical trials group study A5148)
    Stein, JH
    Wu, JW
    Aberg, JA
    McGovern, ME
    Deeg, MA
    Shriver, SL
    Alston, BL
    Greenwald, M
    Lee, D
    Dubé, MP
    [J]. CIRCULATION, 2005, 112 (17) : U894 - U894
  • [34] Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study
    Henrich, Timothy J.
    McLaren, Paul J.
    Rao, Suhas S. P.
    Lin, Nina H.
    Hanhauser, Emily
    Giguel, Francoise
    Gulick, Roy M.
    Ribaudo, Heather
    de Bakker, Paul I. W.
    Kuritzkes, Daniel R.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2014, 1 (01):
  • [35] A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298
    Wilkin, Timothy J.
    Chen, Huichao
    Cespedes, Michelle S.
    Leon-Cruz, Jorge T.
    Godfrey, Catherine
    Chiao, Elizabeth Y.
    Bastow, Barbara
    Webster-Cyriaque, Jennifer
    Feng, Qinghua
    Dragavon, Joan
    Coombs, Robert W.
    Presti, Rachel M.
    Saah, Alfred
    Cranston, Ross D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 67 (09) : 1339 - 1346
  • [36] Recombinant human gamma interferon in human immunodeficiency virus-infected children:: Safety, CD4+-Lymphocyte count, viral load, and neutrophil function (AIDS Clinical Trials Group protocol 211)
    Shearer, WT
    Kline, MW
    Abramson, SL
    Fenton, T
    Starr, SE
    Douglas, SD
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1999, 6 (03) : 311 - 315
  • [37] A PILOT-STUDY TO EVALUATE THE DEVELOPMENT OF RESISTANCE TO NEVIRAPINE IN ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH CD4 CELL COUNTS OF GREATER-THAN-500/MM(3) - AIDS CLINICAL-TRIALS GROUP PROTOCOL-208
    HAVLIR, D
    MCLAUGHLIN, MM
    RICHMAN, DD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (05): : 1379 - 1383
  • [38] Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy:: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
    Dubé, MP
    Stein, JH
    Aberg, JA
    Fichtenbaum, CJ
    Gerber, JG
    Tashima, KT
    Henry, WK
    Currier, JS
    Sprecher, D
    Glesby, MJ
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (05) : 613 - 627
  • [39] Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377)
    Eshleman, SH
    Krogstad, P
    Jackson, JB
    Wang, YG
    Lee, S
    Wei, LJ
    Cunningham, S
    Wantman, M
    Wiznia, A
    Johnson, G
    Nachman, S
    Palumbo, P
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (12): : 1732 - 1738
  • [40] A Randomized Clinical Trial of Human Papillomavirus (HPV) Test-and-Treat as Compared to Cytology-Based Screening for Prevention of Cervical Cancer Among Women Living With Human Immunodeficiency Virus (HIV): AIDS Clinical Trials Group Protocol A5282
    Wilkin, Timothy
    Chen, Huichao
    Sahasrabuddhe, Vikrant
    Matining, Roy
    Mngqibisa, Rosie
    Chinula, Lameck
    Mbilizi, Yamikani
    Magure, Tsitsi
    Omoz-Oarhe, Ayotunde E.
    Rassool, Mohammed
    Riviere, Cynthia
    Bhosale, Rhamesh
    Godbole, Sheela
    Naranjo, Reena
    Coombs, Robert
    Michelow, Pamela
    Godfrey, Catherine
    Firnhaber, Cynthia
    [J]. CLINICAL INFECTIOUS DISEASES, 2022, 75 (08) : 1280 - 1288
12345